BioMap Announces 11 Collaborations at Hong Kong AI Bio-Computing Summit

BioMap announced collaborations with 11 partners at the International Bio-Computing Innovation Summit 2026 in Hong Kong, with seven projects unveiled at the morning launch ceremony. The summit opened at the Hong Kong Convention and Exhibition Centre on November 6, according to PR Newswire.

BioMap's Eleven InnoHub Partnerships

BioMap, a developer of AI foundation models for life sciences, hosted the summit with support from the Hong Kong Investment Corporation Limited (HKIC). Officiating guests included Paul Chan, Financial Secretary of the HKSAR Government; Clara Chan, Chief Executive Officer of HKIC; and Wei Liu, Co-Founder and CEO of BioMap.

In medical research, BioMap and the University of Hong Kong are advancing the next phase of the Breast Cancer Virtual Cell Large Model project, using AI to simulate the functioning of breast cancer cells. BioMap is also working with Hong Kong Baptist University to establish an AI Traditional Chinese Medicine Joint Laboratory, combining AI analysis with experimental validation to investigate the mechanisms of action of TCM ingredients. A collaboration with PepLib on the Novel Peptide Drug Incubation initiative will use AI to accelerate R&D of innovative peptide and cyclic peptide therapeutics.

In agricultural technology, BioMap and Soy-Sky FarmTech will advance an AI Breeding Platform combining biological foundation models with crop genetic and trait data to support breeding decisions and jointly develop a Belt and Road AI Agricultural Innovation Ecosystem. BioMap will work with DEFTA Partners on the DEFTA Overseas Market Expansion Program, exploring research and industry collaboration in Japan and other overseas markets.

In R&D infrastructure, BioMap will work with Coyote Bioscience on an "AI + Biology" initiative supporting molecular point-of-care testing in Hong Kong, and with HiDream.ai on a Cross-Scale Virtual Organism Model. The afternoon ceremony featured four additional organizations, including Temasek Life Sciences Laboratory, with plans to jointly establish an AI Bio-Computing Center in Singapore, and Revvity, on an AI biomanufacturing laboratory.

MegaStream TechBio and BioMap's Funding Record

BioMap and Harbour BioMed jointly established MegaStream TechBio to develop a fully automated closed-loop workflow integrating computational and laboratory experiments through an "AI × Bio" dual-native approach. MegaStream TechBio CEO Kyler Lei made his first public appearance, outlining the AIDD 3.0 vision and advancing the FIC/BIC pipeline layout.

According to akta.pro company records, BioMap's xTrimo V4 foundation model has 268 billion parameters and supports more than 800 institutional users worldwide. The records list two funding rounds, including a 2024-06 round led by Hong Kong Investment Corporation Limited and a 2021-08 Series A of $100 million led by GGV Capital and Jiyuan Capital.

MegaStream TechBio's June Announcement

In June 2026, Harbour BioMed and BioMap announced a strategic partnership to jointly launch MegaStream TechBio, an AI-native pipeline company focused on developing complex biologics for global markets, Yahoo reported. Tipranks reported the same month that HBM Holdings Ltd. entered a long-term global strategic partnership with BioMap to launch MegaStream TechBio, focused on discovering and developing complex biologics.

Hong Kong's Biotech Investment Push

The Hong Kong Investment Corporation is increasing investments in biotech companies to establish the city as a global hub for biomedical innovation, supported by strategic government initiatives, the South China Morning Post reported in August 2026.